Duque, Michael
Duque, Michael was paid $254K by Medicaid between Jan 2018 and Mar 2022, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoDUQUE, MICHAEL
MIDDLETOWN, RI 02842
MIDDLETOWN, RI 02842
33aNPI1871816488assigned 03/10/2010
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$254K
24GClaims8,758
24DCodes billed37
24AFirst – last monthJan 2018 – Mar 2022
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in Rhode Island
Rank by total paid#13 of 80
Median peer was paid$16K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,227 | $47K | |
| 2019 | 41 | $3K | |
| 2020 | 820 | $18K | |
| 2021 | 6,182 | $170K | |
| 2022 | 488 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 1,238 | 1,037 | $81K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 1,048 | 925 | $51K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9.8% | 487 | 446 | $25K |
| 82607 | 3.4% | 337 | 323 | $9K | |
| 80061 | Lipid panel | 3.2% | 281 | 256 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.8% | 238 | 221 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.8% | 462 | 418 | $7K |
| 93000 | 2.7% | 392 | 369 | $7K | |
| 84439 | 2.6% | 424 | 386 | $7K | |
| 82746 | 2.3% | 316 | 303 | $6K | |
| 86803 | 2.3% | 250 | 231 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.0% | 197 | 195 | $5K |
25 more codes
| 86706 | 1.9% | 263 | $5K | |
| 87340 | 1.6% | 239 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 322 | $4K |
| 80053 | Comprehensive metabolic panel | 1.4% | 223 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 48 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 48 | $3K |
| 86592 | <1% | 228 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 18 | $1K |
| 84466 | <1% | 44 | $1K | |
| 86705 | <1% | 51 | $959.87 | |
| 83540 | <1% | 82 | $947.58 | |
| 86704 | <1% | 44 | $882.83 | |
| 80050 | General health panel | <1% | 15 | $822.38 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $810.00 |
| 81002 | <1% | 347 | $799.84 | |
| 82044 | <1% | 220 | $792.10 | |
| 96127 | <1% | 293 | $782.22 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 429 | $704.91 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 75 | $639.13 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 15 | $511.71 |
| 82728 | <1% | 14 | $326.50 | |
| 99407 | <1% | 14 | $254.74 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $215.20 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $171.05 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 15 | $160.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.